Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2256294 in aneurysmal subarachnoid hemorrhage
NCT03318783Phase 2Completed
- Sponsor
- Oregon Health & Science University
- Start
- May 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GSK2256294 in aneurysmal subarachnoid hemorrhage (SAH), sponsored by Oregon Health & Science University. Started May 2018; status: completed.
02
Drugs
GSK2256294
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT03318783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03318783.